Position in CORT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$38,280,954
+$19,633,307 QoQ
Shares Held
440,264
-4.8% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#33
of 421 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Trust Walden Corp holds $230,816,361 across 5 Biotechnology names. CORT ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
443,123 | $106,779,348 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,083,062 | $84,771,262 | |
| 3 | CORT |
Corcept Therapeutics Inc
This page
|
440,264 | $38,280,954 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,193 | $743,883 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
485 | $240,914 |
All Filings in CORT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,280,954 | 440,264 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $18,647,647 | 462,606 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $18,361,384 | 527,626 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $46,729,511 | 562,261 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $41,990,084 | 572,072 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $66,795,855 | 584,800 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $45,303,683 | 899,061 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $70,066,762 | 1,513,975 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $51,460,878 | 1,583,899 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $46,225,992 | 1,835,093 | Shares | Defined | 2024-04-22 | |
| 2023-12-31 | $59,988,091 | 1,846,924 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $49,787,030 | 1,827,047 | Shares | Defined | 2023-10-18 | |
| 2023-06-30 | $44,418,943 | 1,996,357 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $41,569,416 | 1,919,179 | Shares | Defined | 2023-04-19 | |
| 2022-12-31 | $37,497,966 | 1,846,281 | Shares | Defined | 2023-01-20 | |
| 2022-09-30 | $34,827,298 | 1,358,319 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $31,176,483 | 1,311,038 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $29,249,246 | 1,298,812 | Shares | Defined | 2022-04-20 | |
| 2021-12-31 | $20,413,938 | 1,031,007 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $20,897,109 | 1,061,845 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $16,507,722 | 750,351 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $18,331,741 | 770,565 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $10,721,519 | 409,844 | Shares | Defined | 2021-01-15 | |
| No filing history on record for this holder in this stock. | ||||||